410 related articles for article (PubMed ID: 38288116)
61. The role of podocytes in glomerular pathobiology.
Asanuma K; Mundel P
Clin Exp Nephrol; 2003 Dec; 7(4):255-9. PubMed ID: 14712353
[TBL] [Abstract][Full Text] [Related]
62. Interleukin-9 protects from early podocyte injury and progressive glomerulosclerosis in Adriamycin-induced nephropathy.
Xiong T; Attar M; Gnirck AC; Wunderlich M; Becker M; Rickassel C; Puelles VG; Meyer-Schwesinger C; Wiech T; Nies JF; Divivier M; Fuchs T; Schulze Zur Wiesch J; Taipaleenmäki H; Hoxha E; Wirtz S; Huber TB; Panzer U; Turner JE
Kidney Int; 2020 Sep; 98(3):615-629. PubMed ID: 32446933
[TBL] [Abstract][Full Text] [Related]
63. Mechanisms of Podocyte Detachment, Podocyturia, and Risk of Progression of Glomerulopathies.
Trimarchi H
Kidney Dis (Basel); 2020 Sep; 6(5):324-329. PubMed ID: 33490112
[TBL] [Abstract][Full Text] [Related]
64. Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria.
Kang YS; Li Y; Dai C; Kiss LP; Wu C; Liu Y
Kidney Int; 2010 Aug; 78(4):363-73. PubMed ID: 20505657
[TBL] [Abstract][Full Text] [Related]
65. Role of Podocyte Injury in Glomerulosclerosis.
Lu CC; Wang GH; Lu J; Chen PP; Zhang Y; Hu ZB; Ma KL
Adv Exp Med Biol; 2019; 1165():195-232. PubMed ID: 31399967
[TBL] [Abstract][Full Text] [Related]
66. The Pathophysiologic Role of Gelsolin in Chronic Kidney Disease: Focus on Podocytes.
Yu CJ; Damaiyanti DW; Yan SJ; Wu CH; Tang MJ; Shieh DB; Liu PP; Liu PY
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948078
[TBL] [Abstract][Full Text] [Related]
67. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
[TBL] [Abstract][Full Text] [Related]
68. Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.
Kistler AD; Singh G; Altintas MM; Yu H; Fernandez IC; Gu C; Wilson C; Srivastava SK; Dietrich A; Walz K; Kerjaschki D; Ruiz P; Dryer S; Sever S; Dinda AK; Faul C; Reiser J
J Biol Chem; 2013 Dec; 288(51):36598-609. PubMed ID: 24194522
[TBL] [Abstract][Full Text] [Related]
69. Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.
Lee HS
Cell Tissue Res; 2012 Jan; 347(1):129-40. PubMed ID: 21541658
[TBL] [Abstract][Full Text] [Related]
70. Autophagy is activated to protect against podocyte injury in adriamycin-induced nephropathy.
Yi M; Zhang L; Liu Y; Livingston MJ; Chen JK; Nahman NS; Liu F; Dong Z
Am J Physiol Renal Physiol; 2017 Jul; 313(1):F74-F84. PubMed ID: 28404589
[TBL] [Abstract][Full Text] [Related]
71. Slit diaphragm protein Neph1 and its signaling: a novel therapeutic target for protection of podocytes against glomerular injury.
Arif E; Rathore YS; Kumari B; Ashish F; Wong HN; Holzman LB; Nihalani D
J Biol Chem; 2014 Apr; 289(14):9502-18. PubMed ID: 24554715
[TBL] [Abstract][Full Text] [Related]
72. Glomerular Endothelial Cell-Derived microRNA-192 Regulates Nephronectin Expression in Idiopathic Membranous Glomerulonephritis.
Müller-Deile J; Sopel N; Ohs A; Rose V; Gröner M; Wrede C; Hegermann J; Daniel C; Amann K; Zahner G; Schiffer M
J Am Soc Nephrol; 2021 Nov; 32(11):2777-2794. PubMed ID: 34716242
[TBL] [Abstract][Full Text] [Related]
73. Live or Let Die: Is There any Cell Death in Podocytes?
Braun F; Becker JU; Brinkkoetter PT
Semin Nephrol; 2016 May; 36(3):208-19. PubMed ID: 27339386
[TBL] [Abstract][Full Text] [Related]
74. Proteome Analysis of Isolated Podocytes Reveals Stress Responses in Glomerular Sclerosis.
Koehler S; Kuczkowski A; Kuehne L; Jüngst C; Hoehne M; Grahammer F; Eddy S; Kretzler M; Beck BB; Höhfeld J; Schermer B; Benzing T; Brinkkoetter PT; Rinschen MM
J Am Soc Nephrol; 2020 Mar; 31(3):544-559. PubMed ID: 32047005
[TBL] [Abstract][Full Text] [Related]
75. Molecular and cellular events mediating glomerular podocyte dysfunction and depletion in diabetes mellitus.
Anil Kumar P; Welsh GI; Saleem MA; Menon RK
Front Endocrinol (Lausanne); 2014; 5():151. PubMed ID: 25309512
[TBL] [Abstract][Full Text] [Related]
76. The role of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis.
Schwartz MM
Ren Fail; 2000 Nov; 22(6):663-84. PubMed ID: 11104157
[TBL] [Abstract][Full Text] [Related]
77. CD147/Basigin Deficiency Prevents the Development of Podocyte Injury through FAK Signaling.
Yoshioka T; Kosugi T; Masuda T; Watanabe T; Ryuge A; Nagaya H; Maeda K; Sato Y; Katsuno T; Kato N; Ishimoto T; Yuzawa Y; Maruyama S; Kadomatsu K
Am J Pathol; 2019 Jul; 189(7):1338-1350. PubMed ID: 31014956
[TBL] [Abstract][Full Text] [Related]
78. Podocyte-associated talin1 is critical for glomerular filtration barrier maintenance.
Tian X; Kim JJ; Monkley SM; Gotoh N; Nandez R; Soda K; Inoue K; Balkin DM; Hassan H; Son SH; Lee Y; Moeckel G; Calderwood DA; Holzman LB; Critchley DR; Zent R; Reiser J; Ishibe S
J Clin Invest; 2014 Mar; 124(3):1098-113. PubMed ID: 24531545
[TBL] [Abstract][Full Text] [Related]
79. The beneficial role of retinoids in glomerular disease.
Mallipattu SK; He JC
Front Med (Lausanne); 2015; 2():16. PubMed ID: 25853135
[TBL] [Abstract][Full Text] [Related]
80. Prohibitin Signaling at the Kidney Filtration Barrier.
Ising C; Brinkkoetter PT
Adv Exp Med Biol; 2017; 982():563-575. PubMed ID: 28551807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
